Pinocarvone is a bicyclic monoterpene ketone occurring as a minor constituent of essential oils, with herbaceous, minty, camphoraceous odor character.
Aroma and practical use
- Use the recorded herbaceous, minty, camphoraceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
There are no constituent-specific outcome findings in this report. No therapeutic benefit is inferred from its presence.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
recorded reference · IFRA Code of Practice (49th Amendment) recommended maximum use level in the fragrance concentrate, as aggregated by The Good Scents Company (thegoodscentscompany.com/data/rw1054321.html)Screening assumption (provisional). It is not a verified constituent-specific exposure limit.
model fallback · IFRA Code of Practice (49th Amendment) recommended maximum use level in the fragrance concentrate, as aggregated by The Good Scents Company (thegoodscentscompany.com/data/rw1054321.html)Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (3)
- Second-pass verification (2026-07-13) located a TGSC-aggregated IFRA Code of Practice (49th Amendment) recommended maximum use level of 2% in the fragrance concentrate for pinocarvone, but could not retrieve the underlying RIFM full-text assessment to confirm the sensitization/phototoxicity rationale behind that number (two direct PDF fetch attempts and one WebSearch attempt all failed to surface RIFM's endpoint-level conclusions for this specific material). A whole-oil SDS (Oshadhi chamomile roman) lists pinocarvone as a minor constituent but attributes its Skin Sens. 1 mixture classification to other named allergens, not to pinocarvone specifically. dermal_limit_pct is recorded provisionally from the IFRA/TGSC figure with dermal_limit_verified left false pending primary-source confirmation.
- No constituent-specific outcome findings are available in this report.
- No public source links are attached to this constituent report.